Relief Therapeutics Holding SA (ETR:RLF) | WebDisclosure

Basculer en Français

9821	Companies
197095	Keywords
128173	Articles
104823	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

PRESS RELEASE

published on 10/08/2024 at 07:00, 1 year 4 months ago

Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
Relief Therapeutics reports promising preliminary results of RLF-TD011 clinical trial for epidermolysis bullosa, showing reduced Staphylococcus aureus and improved microbiome diversity

Microbiome Clinical Trial Relief Therapeutics RLF-TD011 Epidermolysis Bullosa
BRIEF

published on 10/04/2024 at 07:05, 1 year 4 months ago

Relief Therapeutics annonce des résultats d'étude positifs pour le traitement de la phénylcétonurie

THÉRAPEUTIQUE DE SECOURS RLF-OD032 Phénylcétonurie Dichlorhydrate De Saproptérine Résultats De L'étude Clinique
BRIEF

published on 10/04/2024 at 07:05, 1 year 4 months ago

Relief Therapeutics Reports Positive Study Results for Phenylketonuria Treatment

Relief Therapeutics RLF-OD032 Phenylketonuria Sapropterin Dihydrochloride Clinical Study Results
PRESS RELEASE

published on 10/04/2024 at 07:00, 1 year 4 months ago

Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria
Relief Therapeutics reports positive results from RLF-OD032 proof-of-concept clinical study for Phenylketonuria, showing bioequivalence with KUVAN(R) in managing PKU. RLF-OD032 aims to offer a patient-friendly, portable solution for PKU treatment

Clinical Study Relief Therapeutics RLF-OD032 Bioéquivalence Phenylketonuria
BRIEF

published on 09/23/2024 at 07:05, 1 year 4 months ago

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

FDA Approval Relief Therapeutics Milestone Payment Niemann-Pick Disease SWK Funding
BRIEF

published on 09/23/2024 at 07:05, 1 year 4 months ago

Relief Therapeutics annonce un jalon de 2 millions de dollars dans le cadre d'un accord de vente de redevances

Approbation De La FDA THÉRAPEUTIQUE DE SECOURS Paiement D'étape Maladie De Niemann-Pick Financement SWK
PRESS RELEASE

published on 09/23/2024 at 07:00, 1 year 4 months ago

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement
Relief Therapeutics announced $2 million milestone payment under royalty sales agreement after FDA approval of arimoclomol for Niemann-Pick Disease Type C treatment

FDA Approval Relief Therapeutics Milestone Payment Arimoclomol Royalty Sales Agreement

Accesswire

Published on 02/08/2026 at 21:00, 7 hours 19 minutes ago

Banyan Gold Extends Airstrip and High-Grade Mineralization to 350m Vertical Depth, Yukon, Canada
Published on 02/07/2026 at 01:00, 2 days 3 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 2 days 5 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 2 days 6 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 12 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 1 day 7 hours ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 11 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 11 hours ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 2 days 8 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 days 10 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 2 days 9 hours ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 2 days 9 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 12 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 2 days 12 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 2 days 20 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE